Elevaris Medical Devices: The New Era of Precision Medical Devices from Spectra and XLPT

Elevaris Medical Devices: Redefining the Future of Healthcare

In January 2025, Spectra Medical Devices and XL Precision Technologies announced their new unified brand identity as Elevaris Medical Devices. This significant rebranding symbolizes an amalgamation of expertise and a commitment to enhancing the development and manufacturing of precision medical devices.

A Historical Perspective

The merger of Spectra and XLPT, which took place in September 2024, brought together two stalwart Contract Development and Manufacturing Organizations (CDMOs) that have long served the medical device sector. Spectra is renowned for its extensive design and manufacturing capabilities alongside exceptional technical support to Original Equipment Manufacturers (OEMs). On the other hand, XLPT has established a strong reputation for its precision in crafting microcomponents and intricate tubing.

This newly established brand, Elevaris Medical Devices, seeks to honor the rich legacy of both organizations while showcasing their commitment to providing customers with knowledge, collaboration, and advanced manufacturing capabilities.

Leadership Insights

Richard Zrebiec, CEO of Elevaris Medical Devices, noted, "The merger brought together two trusted entities whose strengths are complementary. Today, as we complete our integration, operating under a unified brand underscores our shared commitment to our customers' success."

He elaborated on how Elevaris is uniquely positioned to support medical technology companies, leveraging collective skills and insights from an extensive team of design and development experts. Their mission is clear: they aim to provide design, development, and manufacturing solutions that bolster their customers' success.

Commitment to Excellence

Elevaris Medical Devices stands out by offering complete support from concept to production, ensuring that their clients can advance the next generation of medical devices. Zrebiec emphasized that their organization is determined to improve global health through innovation in medical technology, making them an unrivaled partner in the evolution of precision medical products.

Product Portfolio

The company operates as a CDMO for industry-leading multinational healthcare corporations, ambitious OEMs, and emerging technology firms. Elevaris is particularly noted for its expertise in creating custom procedural needles, precision microcomponents, complex tubing, and subassemblies. Moreover, they provide a diverse range of accompanying pharmaceutical products, surgical instruments, and medical supplies essential in today's healthcare system.

Global Reach

With over 300 employees distributed across North America, the United Kingdom, and South Korea, Elevaris Medical Devices is well-equipped to cater to a global clientele while maintaining high standards in manufacturing precision medical devices.

Conclusion

The launch of Elevaris Medical Devices encapsulates an exciting chapter in the realm of medical device engineering and manufacturing. By harnessing the combined strengths and expertise of its founding entities, Elevaris is poised to lead the market with innovative solutions that significantly impact healthcare delivery. As they embark on this journey into a new era, they reaffirm their dedication to spearheading advancements in medical technology and enhancing patient outcomes worldwide.

For more information about Elevaris Medical Devices and to explore their offerings, visit elevarismedical.com.